Advertisement
Screener

ImmuCell Corporation (ICCC) Material Contracts

ImmuCell Corporation Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2026-08-13: Form 10-Q; Exhibit 10.2; Description 2025 Stock Option and Incentive Plan, as approved by the Board of Directors on November 7, 2025, revised on March 26, 2026 and April 7, 2026 and approved by the Company’s stockholders at the Annual Meeting of Stockholders on June 11, 2026..
  • 2026-08-13: Form 10-Q; Exhibit 10.1; Description Settlement Deed, dated as of May 6, 2026, between the Company and Norbrook Laboratories Limited..
  • 2026-05-13: Form 10-K/A; Exhibit 10.7; Description 2025 Stock Option and Incentive Plan, as approved by the Board of Directors on November 7, 2025 and revised on March 26, 2026 and April 7, 2026..
  • 2026-03-30: Form 10-K; Exhibit 10.9; Description Form of Director Stock Option for 2025 Plan..
FiledFormExhibitDescription
2026-08-1310-Q10.22025 Stock Option and Incentive Plan, as approved by the Board of Directors on November 7, 2025, revised on March 26, 2026 and April 7, 2026 and approved by the Company’s stockholders at the Annual Meeting of Stockholders on June 11, 2026.
2026-08-1310-Q10.1Settlement Deed, dated as of May 6, 2026, between the Company and Norbrook Laboratories Limited.
2026-05-1310-K/A10.72025 Stock Option and Incentive Plan, as approved by the Board of Directors on November 7, 2025 and revised on March 26, 2026 and April 7, 2026.
2026-03-3010-K10.9Form of Director Stock Option for 2025 Plan.
2026-03-3010-K10.8Form of Incentive Stock Option Agreement for 2025 Plan.
2026-03-3010-K10.72025 Stock Option and Incentive Plan, as approved by the Board of Directors on November 7, 2025 and revised on March 26, 2026.
2026-02-028-K10.3Performance-Based Incentive Stock Option Agreement between the Company and Paul Olivier te Boekhorst
2026-02-028-K10.2Employment Agreement between the Company and Bobbi Jo Brockmann dated as of January 27, 2026.
2026-02-028-K10.1Employment Agreement between the Company and Timothy C. Fiori dated as of January 27, 2026.
2025-09-308-K10.2Confidential Information, Inventions and Noncompete Agreement between the Company and Olivier te Boekhorst, signed September 29, 2025 and effective upon commencement of employment.
2025-09-308-K10.1Employment Agreement between the Company and Olivier te Boekhorst dated as of September 29, 2025.
2025-08-258-K10.1ALLONGE TO AND AMENDMENT OF LINE OF CREDIT LOAN BETWEEN THE COMPANY AND MAINE COMMUNITY BANK DATED AUGUST 20, 2025
2025-08-128-K10.2PROMISSORY NOTE EXECUTED BY THE COMPANY IN FAVOR OF MAINE COMMUNITY BANK DATED AS OF AUGUST 7, 2025
2025-08-128-K10.1LOAN AGREEMENT BETWEEN THE COMPANY AND MAINE COMMUNITY BANK DATED AS OF AUGUST 7, 2025
2025-04-078-K10.1INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND TIMOTHY C. FIORI DATED AS OF APRIL 4, 2025
2025-03-2810-K10.11AMENDED AND RESTATED INCENTIVE COMPENSATION AND SEVERANCE AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 27, 2025
2025-03-2810-K10.10INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH 27, 2025
2024-12-098-K10.1EMPLOYMENT AND SEPARATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS DATED AS OF DECEMBER 6, 2024
2024-12-028-K10.1AMENDING AGREEMENT BETWEEN THE COMPANY AND NORBROOK LABORATORIES LIMITED DATED AS OF NOVEMBER 29, 2024
2024-09-248-K10.1FIFTH AMENDMENT OF INDENTURE OF LEASE FOR PREMISES LOCATED IN PORTLAND, MAINE BETWEEN THE COMPANY AND TVP, LLC DATED AS OF SEPTEMBER 20, 2024
2024-06-148-K10.1FOURTH AMENDMENT OF INDENTURE OF LEASE FOR PREMISES LOCATED IN PORTLAND, MAINE BETWEEN THE COMPANY AND TVP, LLC DATED AS OF JUNE 11, 2024
2024-04-098-K10.1CONSENT AND FIRST AMENDMENT TO ECONOMIC RECOVERY LOAN PROGRAM LOAN AGREEMENT, DATED APRIL 8, 2024, BY AND BETWEEN THE COMPANY AND THE FINANCE AUTHORITY OF MAINE
2024-04-0110-K10.11FOURTH AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 27, 2024
2024-04-0110-K10.8FIFTH AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS DATED AS OF MARCH 27, 2024
2024-03-068-K10.1AMENDING AGREEMENT BETWEEN THE COMPANY AND NORBROOK LABORATORIES LIMITED DATED AS OF MARCH 4, 2024
2024-02-278-K10.1ALLONGE TO AND AMENDMENT OF LINE OF CREDIT BETWEEN THE COMPANY AND GORHAM SAVINGS BANK, DATED FEBRUARY 22, 2024
2023-11-168-K10.1THIRD AMENDMENT OF INDENTURE OF LEASE FOR PREMISES LOCATED IN PORTLAND, MAINE BETWEEN THE COMPANY AND TVP, LLC DATED AS OF NOVEMBER 14, 2023
2023-07-218-K10.4ECONOMIC RECOVERY LOAN PROGRAM LOAN AGREEMENT, BY AND BETWEEN IMMUCELL CORPORATION AND THE FINANCE AUTHORITY OF MAINE DATED JULY 17, 2023
2023-07-218-K10.3ECONOMIC RECOVERY/SSBCI PROGRAM LOAN PROMISSORY NOTE FOR $1,000,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF THE FINANCE AUTHORITY OF MAINE DATED JULY 17, 2023
2023-07-218-K10.2LOAN AGREEMENT, BY AND BETWEEN IMMUCELL CORPORATION AND GORHAM SAVINGS BANK DATED JULY 17, 2023
2023-07-218-K10.1TERM NOTE FOR $2,000,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF GORHAM SAVINGS BANK DATED JULY 17, 2023
2023-03-2910-K10.23ALLONGE TO AND AMENDMENT OF LINE OF CREDIT LOAN FOR UP TO $1,000,000 BETWEEN THE COMPANY AND GORHAM SAVINGS BANK DATED MARCH 23, 2022
2023-03-2910-K10.15THIRD AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 28, 2023
2023-03-2910-K10.13AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH 28, 2023
2023-03-2910-K10.10FOURTH AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS DATED AS OF MARCH 28, 2023
2023-03-2910-K10.7AMENDMENT TO THE 2017 STOCK OPTION AND INCENTIVE PLAN OF THE COMPANY
2022-11-2110-Q10THIRD AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS DATED AS OF NOVEMBER 11, 2022
2022-03-3010-K10.11SECOND AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 28, 2022
2022-03-3010-K10.10INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH 28, 2022
2022-03-3010-K10.9AMENDED AND RESTATED SEPARATION AND DEFERRED COMPENSATION AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH 28, 2022
2022-03-3010-K10.8SECOND AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS DATED AS OF MARCH 28, 2022
2021-04-158-K10.1SECURITIES PURCHASE AGREEMENT, DATED APRIL 14, 2021, BY AND AMONG IMMUCELL CORPORATION AND CERTAIN PURCHASERS
2021-03-3010-K10.12AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 29, 2021
2020-12-178-K10.2LOAN AGREEMENT FOR $1,500,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF GORHAM SAVINGS BANK DATED DECEMBER 15, 2020
2020-12-178-K10.1TERM NOTE FOR $1,500,000 EXECUTED BY IMMUCELL CORPORATION IN FAVOR OF GORHAM SAVINGS BANK DATED DECEMBER 15, 2020.
2020-03-2710-K10.21AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT BETWEEN THE COMPANY AND BOBBI JO BROCKMANN DATED AS OF MARCH 25, 2020
2020-03-2710-K10.20SEVERANCE AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM DATED AS OF MARCH 25, 2020
2020-03-2710-K10.9+FORM OF INCENTIVE STOCK OPTION AGREEMENT
2019-03-2210-K10.21INCENTIVE COMPENSATION AGREEMENT DATED MARCH 21, 2019 BETWEEN THE COMPANY AND ELIZABETH L. WILLIAMS
2017-08-1410-Q10.2AMENDMENT TO SUPPLY AGREEMENT BETWEEN THE COMPANY AND PLAS-PAK INDUSTRIES, INC. (NOW OWNED BY NORDSON CORPORATION) DATED AS OF JULY 24, 2017
2017-08-1410-Q10.12017 STOCK OPTION AND INCENTIVE PLAN OF THE COMPANY
2017-07-278-K/A10.1SECURITIES PURCHASE AGREEMENT, DATED JULY 27, 2017, BY AND AMONG IMMUCELL
2017-07-278-K10.1SECURITIES PURCHASE AGREEMENT, DATED JULY 27, 2017, BY AND AMONG IMMUCELL
2017-03-3010-K10.24MORTGAGE LOAN NOTE FOR $340,000 GIVEN BY THE COMPANY IN FAVOR OF TD BANK N.A. DATED MARCH 16, 2017
2017-03-3010-K10.18AMENDMENT TO CONSTRUCTION LOAN AGREEMENT BETWEEN THE COMPANY AND TD BANK N.A. DATED MARCH 1, 2017
2017-03-3010-K10.17AMENDED AND RESTATED PROMISSORY NOTE ($3,940,000) GIVEN BY THE COMPANY IN FAVOR OF TD BANK N.A. DATED MARCH 1, 2017
2017-03-3010-K10.16AMENDED AND RESTATED PROMISSORY NOTE ($2,560,000) GIVEN BY THE COMPANY IN FAVOR OF TD BANK N.A. DATED MARCH 1, 2017
2016-11-1010-Q10.1STANDARD FORM OF AGREEMENT
2016-10-218-K10.2SECURITIES PURCHASE AGREEMENT
2016-10-218-K10.1REGISTRATION RIGHTS AGREEMENT
2015-11-1210-Q10.1SUPPLY AGREEMENT BETWEEN THE COMPANY AND PLAS-PAK INDUSTRIES, INC. DATED AS OF OCTOBER 14, 2015.
2011-03-2810-K10.7FORM OF INCENTIVE STOCK OPTION AGREEMENT
2011-03-2810-K10.62010 STOCK OPTION AND INCENTIVE PLAN OF THE COMPANY
2010-11-0810-Q10.1CONTRACT MANUFACTURE AGREEMENT
2010-08-1610-Q10.5LOAN AGREEMENT BETWEEN THE COMPANY AND TD BANK, N.A.
2010-08-1610-Q10.4LINE OF CREDIT AGREEMENT AND PROMISSORY NOTE FOR UP TO $500,000
2010-08-1610-Q10.3COMMERCIAL PROMISSORY NOTE FOR $600,000
2010-08-1610-Q10.2COMMERCIAL PROMISSORY NOTE FOR $1,000,000
2010-08-1610-Q10.1DEVELOPMENT AND MANUFACTURING AGREEMENT
2010-03-2910-K10.7AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND JOSEPH H. CRABB
2010-03-2910-K10.6AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND MICHAEL F. BRIGHAM
2009-03-2710-K10.7FORM OF INCENTIVE STOCK OPTION AGREEMENT
2009-03-2710-K10.62000 STOCK OPTION AND INCENTIVE PLAN OF THE REGISTRANT
2009-03-2710-K10.5EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND JOSEPH H. CRABB
2009-03-2710-K10.4EMPLOYMENT AGREEMENT BETWEEN THE REGISTRANT AND MICHAEL F. BRIGHAM
2009-03-2710-K10.2FORM OF INCENTIVE STOCK OPTION AGREEMENT
2009-03-2710-K10.11989 STOCK OPTION AND INCENTIVE PLAN OF THE REGISTRANT

Similar stocks

Stock NameCountryMarket CapPE Ratio
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92